(NYSE: NVS) Novartis Ag's forecast annual revenue growth rate of 2.12% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 10.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Novartis Ag's revenue in 2025 is $51,722,000,000.On average, 3 Wall Street analysts forecast NVS's revenue for 2025 to be $103,856,426,041,507, with the lowest NVS revenue forecast at $102,736,242,323,968, and the highest NVS revenue forecast at $105,001,531,435,177. On average, 3 Wall Street analysts forecast NVS's revenue for 2026 to be $107,084,579,061,472, with the lowest NVS revenue forecast at $104,077,327,923,360, and the highest NVS revenue forecast at $109,676,942,952,150.
In 2027, NVS is forecast to generate $107,875,424,547,264 in revenue, with the lowest revenue forecast at $107,875,424,547,264 and the highest revenue forecast at $107,875,424,547,264.